DEVELOPMENT OF A BIOCOMPATIBLE PRODUCT FOR FICILI_2790 INJURY THERAPY (Q2310940)
Jump to navigation
Jump to search
Project Q2310940 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF A BIOCOMPATIBLE PRODUCT FOR FICILI_2790 INJURY THERAPY |
Project Q2310940 in Italy |
Statements
116,114.0 Euro
0 references
232,228.0 Euro
0 references
50.0 percent
0 references
10 November 2017
0 references
30 June 2021
0 references
ICGEB - INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
0 references
45°40'37.52"N, 13°45'12.31"E
0 references
IL PRESENTE PROGETTO RIGUARDA LO SVILUPPO E IL TESTO IN VITRO E IN VIVO IN MODELLI PRE-CLINICI UN PRODOTTO TERAPEUTICO INNOVATIVO BASATO SULLA COMBINAZIONE DI TRE ELEMENTI (MATRICE EXTRACELLULARE, CELLULE ENDOTELIALI E FATTORI DI CRESCITA), UTILIZZANDO IL BIOREATTORE AUTOMATIZZATO NANT 001 AL FINE DI CONSENTIRE LA STANDARDIZZAZIONE DEL PROCESSO, NONCHé LA RIDUZIONE DI TEMPI E COSTI DEL PROCESSAMENTO DELLE CELLULE ENDOTELIALI AUTOLOGHE (ISOLATE DA UNA BIOPSIA DELLO STESSO PAZIENTE IN CUI VERRAN (Italian)
0 references
THIS PROJECT CONCERNS THE DEVELOPMENT AND THE IN VITRO AND IN VIVO MODELS IN PRE-CLINICAL MODELS OF AN INNOVATIVE THERAPEUTIC PRODUCT BASED ON THE COMBINATION OF THREE ELEMENTS (EXTRACELLULAR MATRIX, ENDOTHELIAL CELLS AND GROWTH DRIVERS), USING THE AUTOMATIC NANT 001 BIOREACTOR IN ORDER TO ALLOW STANDARDISATION OF THE PROCESS, AVOIDANCE OF TIME AND COST OF THE PROCESS OF AUTOLOGOUS ENDOTHELIAL CELLS (ISOLATED BY A PATIENT BIOPSY IN THE SAME PATIENT WHERE VERRAN (English)
0 references
Identifiers
F96C18000230002
0 references